Pathology Doctors in Utah Medicare Details, Address, Contact
206 Pathology doctors found. Showing 201 - 206
 Miss Lily Marsden, M.D. Pathology - Forensic Pathology Medicare: Medicare Enrolled Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-581-2121 |
 Neil G. D. Haycocks, M.D., PH.D. Pathology - Hematology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-816-3850 |
Jacob M. Donnelly, DO Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-581-2121 |
Dr. Justin M. Lohmann, DO Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-816-3850 |
Erik Dean Christensen, M.D. Pathology - Forensic Pathology Medicare: Not Enrolled in Medicare Practice Location: 4451 S 2700 W, Taylorsville, UT 84129 Phone: 801-816-3850 Fax: 801-964-1240 |
James Peters Murphey, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 576 W 900 S, Suite 105, Woods Cross, UT 84010 Phone: 801-298-4214 Fax: 801-298-4217 |
News Archive
Hepatitis C infection varies widely among different Hispanic groups in the U.S.
The first study of hepatitis C infection among different Hispanic groups in the U.S. has found that infection with the virus varies widely, with Puerto Rican Hispanics much more likely than other groups to be infected. The study, led by researchers at Albert Einstein College of Medicine of Yeshiva University, highlights which Hispanic populations would benefit most from increased hepatitis C testing and treatment.
New research reports evaluating nephrology market in Europe released
BioTrends Research Group, Inc. has released two new syndicated market research reports evaluating the nephrology market in Europe. The reports, TreatmentTrends: Renal Anemia and TreatmentTrends: Bone and Mineral Metabolism, are derived from the responses of over 200 European nephrologists polled in May and June, 2010 regarding their approach to managing renal anemia and bone and mineral disturbances in their dialysis and chronic kidney disease patients.
Genentech announces FDA approval of Avastin manufacturing
Genentech has announced that the U.S. Food and Drug Administration approved the supplemental Biologics License Application (sBLA) for the manufacturing of Avastin™ (bevacizumab) bulk drug substance at the company's facility in Vacaville, California.
Intravenous gene therapy protects normal tissue of mice during whole-body radiation
Gene therapy administered intravenously could be an effective agent to protect vital organs and tissues from the effects of ionizing radiation in the event of large-scale exposure from a radiological or nuclear bomb, according to an animal study presented today by University of Pittsburgh researchers at the 49th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.
› Verified 2 days ago
Lehi (4)
Murray (5)
Ogden (12)
Orem (6)
Salt Lake City (151)
St George (5)
Taylorsville (5)
All Cities in UT